Sugi Predict

Sugi Predict / Compounds / Tyrosine

Tyrosine

Tyrosine

SCHEMBL6141122

CC(C)C[C@H](N)C(=O)O.CC(C)[C@H](N)C(=O)O.C[C@@H](O)[C@H](N)C(=O)O.C[C@@H](O)[C@H](N)C(=O)O.C[C@H](N)C(=O)O.C[C@H](N)C(=O)O.NC(=O)CC[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O.N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Tyrosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.43
▸ SLC7A5 Q01650 1/20 0.40
▸ NPY4R P50391 4/20 0.37
▸ NPY1R P25929 3/20 0.37
▸ NPY2R P49146 3/20 0.37
▸ ERAP2 Q6P179 2/20 0.37
▸ IL1RN P18510 1/20 0.37
▸ ITGB3 P05106 1/20 0.36
▸ ITGA2B P08514 1/20 0.36
▸ NTSR2 O95665 1/20 0.35
▸ NTSR1 P30989 1/20 0.35
▸ LNPEP Q9UIQ6 2/20 0.34
▸ NPY5R Q15761 2/20 0.34
▸ BACE1 P56817 2/20 0.34
▸ BACE2 Q9Y5Z0 1/20 0.34
▸ GSR P00390 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ OPRD1 P41143 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tyrosine SCHEMBL1931272 1.00 THRB (0.43) THRBSLC7A5NPY4RNPY1RNPY2R
Tyrosine SCHEMBL9111486 0.90 THRB (0.37) THRBSLC7A5NPY4RNPY1RNPY2R
Tyrosine SCHEMBL8079541 0.87 SLC7A5 (0.53) SLC7A5
Tyrosine SCHEMBL29157665 0.86 THRB (0.40) THRBSLC7A5ERAP2ITGB3ITGA2B
Dl-Phenylalanine SCHEMBL23120449 0.85 THRB (0.46) THRBSLC7A5ITGB3ITGA2BGSR
Tyrosine SCHEMBL28640656 0.85 SLC7A5 (0.41) THRBSLC7A5NPY4RNPY1RNPY2R
Tyrosine SCHEMBL4610453 0.85 SLC7A5 (0.56) THRBSLC7A5ERAP2ITGB3ITGA2B
Tyrosine SCHEMBL5358316 0.85 SLC7A5 (0.56) THRBSLC7A5ERAP2ITGB3ITGA2B
Tyrosine SCHEMBL10722619 0.84 SLC7A5 (0.44) THRBSLC7A5ERAP2ITGB3ITGA2B
Tyrosine SCHEMBL10720159 0.84 SLC7A5 (0.44) THRBSLC7A5ERAP2ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458241-A4 MODIFIED ANTIGEN-PRESENTING CELLS DANA FARBER CANCER INST INC (US) 2005-11-09 — — EP disclosed
US-20050003484-A1 Modified antigen-presenting cells DANA FARBER CANCER INSTITUTE 2005-01-06 — — US disclosed
EP-1458241-A2 MODIFIED ANTIGEN-PRESENTING CELLS DANA-FARBER CANCER INSTITUTE (US) 2004-09-22 — — EP disclosed
WO-2003065977-A9 MODIFIED ANTIGEN-PRESENTING CELLS DANA FARBER CANCER INST INC (US) 2003-10-16 — — WO disclosed
WO-2003065977-A2 MODIFIED ANTIGEN-PRESENTING CELLS DANA-FARBER CANCER INSTITUTE (US) 2003-08-14 — — WO disclosed
US-5651993-A IRRADIATING LEUKOCYTE MIXTURE IN PSORALEN PRESENCE; REACTING WITH PEPTIDE ANTIGENS YALE UNIVERSITY (US) 1997-07-29 — — US disclosed